ADPT
Price
$4.37
Change
+$0.04 (+0.92%)
Updated
Nov 28, 6:59 PM EST
76 days until earnings call
VERV
Price
$11.93
Change
+$0.37 (+3.20%)
Updated
Nov 28, 6:59 PM EST
103 days until earnings call
Ad is loading...

Compare trend and price ADPT vs VERV

Header iconADPT vs VERV Comparison
Open Charts ADPT vs VERVBanner chart's image
Adaptive Biotechnologies
Price$4.37
Change+$0.04 (+0.92%)
Volume$419.36K
CapitalizationN/A
Verve Therapeutics
Price$11.93
Change+$0.37 (+3.20%)
Volume$537.26K
CapitalizationN/A
View a ticker or compare two or three
ADPT vs VERV Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ADPT vs. VERV commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Buy and VERV is a Hold.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (ADPT: $4.37 vs. VERV: $11.93)
Brand notoriety: ADPT: Notable vs. VERV: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 44% vs. VERV: 52%
Market capitalization -- ADPT: $626.87M vs. VERV: $736.98M
ADPT [@Biotechnology] is valued at $626.87M. VERV’s [@Biotechnology] market capitalization is $736.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • ADPT’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, ADPT is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 5 TA indicator(s) are bullish while VERV’s TA Score has 3 bullish TA indicator(s).

  • ADPT’s TA Score: 5 bullish, 3 bearish.
  • VERV’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ADPT is a better buy in the short-term than VERV.

Price Growth

ADPT (@Biotechnology) experienced а +3.55% price change this week, while VERV (@Biotechnology) price change was +4.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.68%. For the same industry, the average monthly price growth was +33.10%, and the average quarterly price growth was +8.38%.

Reported Earning Dates

ADPT is expected to report earnings on Feb 13, 2024.

VERV is expected to report earnings on Mar 11, 2024.

Industries' Descriptions

@Biotechnology (+1.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ADPT with price predictions.
OPEN
A.I.dvisor published
a Summary for VERV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERV($737M) has a higher market cap than ADPT($627M). VERV YTD gains are higher at: -38.346 vs. ADPT (-42.801). ADPT has higher annual earnings (EBITDA): -159.51M vs. VERV (-212.02M). VERV has more cash in the bank: 485M vs. ADPT (371M). VERV has less debt than ADPT: VERV (76.8M) vs ADPT (101M). ADPT has higher revenues than VERV: ADPT (180M) vs VERV (7.63M).
ADPTVERVADPT / VERV
Capitalization627M737M85%
EBITDA-159.51M-212.02M75%
Gain YTD-42.801-38.346112%
P/E RatioN/A3.16-
Revenue180M7.63M2,360%
Total Cash371M485M76%
Total Debt101M76.8M132%
TECHNICAL ANALYSIS
Technical Analysis
ADPTVERV
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYCX22.050.06
+0.27%
American Century Real Estate C
PWTYX46.210.10
+0.22%
UBS US Allocation P
NSRIX19.740.02
+0.10%
Northern Global Sustainability Index I
BMRRX29.00-0.15
-0.51%
BlackRock Mid-Cap Growth Equity R
WSCVX14.48-0.19
-1.30%
North Star Small Cap Value Investor

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+0.92%
AXON - ADPT
56%
Loosely correlated
-0.48%
VCYT - ADPT
56%
Loosely correlated
-2.24%
DNLI - ADPT
53%
Loosely correlated
+2.12%
BEAM - ADPT
52%
Loosely correlated
+2.09%
MDGL - ADPT
51%
Loosely correlated
-3.22%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+3.20%
BEAM - VERV
62%
Loosely correlated
+2.09%
CRSP - VERV
61%
Loosely correlated
-1.33%
NTLA - VERV
55%
Loosely correlated
+0.33%
MDGL - VERV
52%
Loosely correlated
-3.22%
PGEN - VERV
50%
Loosely correlated
-0.88%
More